{"id": "1356580678201204736", "creation": 1612269012.0, "user_id": "27013292", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 10814, "reply_count": 439, "like_count": 20764, "quote_count": 4083}}, "text": "NEW\u2014Interim analysis of Russian #COVID19 #vaccine phase 3 trial involving nearly 20,000 participants suggests a two-dose regimen has an efficacy of 91.6% against symptomatic #COVID19. No serious adverse events were deemed to be associated with vaccination. https://t.co/40sM7f2nbS https://t.co/Hzrs34uCWr", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#COVID19"]}